Digital biomarkers for Alzheimer's disease (AD) represent an emerging class of objective, continuous measurements derived from digital devices that can detect early cognitive decline, track disease progression, and monitor treatment responses. These biomarkers offer significant advantages over traditional clinical assessments: they are non-invasive, cost-effective, can be collected passively in home settings, and provide high-frequency longitudinal data.
Gait abnormalities are detectable years before clinical diagnosis of AD. Digital gait analysis uses wearable sensors (accelerometers, gyroscopes) to measure:
Diagnostic Performance:
Actigraphy uses wrist-worn devices to monitor sleep-wake cycles, activity levels, and circadian rhythms. Sleep disturbances are common in AD and often precede cognitive symptoms:
Clinical Utility:
Smartphone applications can deliver standardized cognitive assessments that traditionally required in-clinic administration:
Advantages:
Digital speech analysis examines acoustic features and linguistic content for cognitive decline markers:
Research Findings:
Digital pen devices and tablet styluses capture fine motor control and writing patterns:
Continuous monitoring through ambient sensors in smart homes:
| Digital Biomarker Type | Cost | Accessibility | Regulatory Status |
|---|---|---|---|
| Wearable gait analysis | $50-300 | High | FDA Class I/II exempt |
| Actigraphy | $100-500 | High | FDA cleared devices available |
| Smartphone cognitive tests | $0-50 | Very High | LDTs, not FDA cleared |
| Speech analysis | $0-100 | Very High | Research phase |
| Passive home monitoring | $500-2000 | Moderate | Varies by application |
The AT(N) classification system (Amyloid, Tau, Neurodegeneration) can be enhanced with digital biomarkers:
| AT(N) Category | Digital Biomarker Correlates |
|---|---|
| A (Amyloid) | Sleep efficiency, circadian rhythm amplitude |
| T (Tau) | Gait variability, speech metrics |
| N (Neurodegeneration) | Activity levels, motor performance |
Schoön et al. Gait analysis in dementia: A biomarker approach. Brain. 2018. ↩︎
Muurling et al. Objective gait parameters in Alzheimer's disease and related disorders. Alzheimer's & Dementia. 2021. ↩︎
Muir-Hunter et al. Cognitive and gait asymmetry in older adults. Gait & Posture. 2014. ↩︎
Padala et al. Gait velocity as a predictor of progression in MCI. Journal of Geriatric Psychiatry and Neurology. 2017. ↩︎
Howcroft et al. Characterization of gait stride-to-stride variability. BMC Geriatrics. 2017. ↩︎
Spira et al. Sleep duration and Alzheimer's disease biomarkers. Neurology. 2017. ↩︎
Bokenberger et al. Sleep disturbances and Alzheimer's disease. Sleep Medicine Reviews. 2018. ↩︎
Videnovic et al. Circadian rhythms in Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2014. ↩︎
Naska et al. Physical activity and Alzheimer's disease. European Review of Aging and Physical Activity. 2017. ↩︎
Ancoli-Israel et al. Actigraphy validation with polysomnography. Sleep and Breathing. 2015. ↩︎
Westerberg et al. Actigraphy predicts progression to AD. Journal of Alzheimer's Disease. 2012. ↩︎
Kaye et al. Smartphone cognitive testing. Alzheimer's & Dementia. 2014. ↩︎
Rentz et al. Tablet-based cognitive assessment. Alzheimer's & Dementia. 2016. ↩︎
Wojtalik et al. Mobile cognitive testing for dementia. Journal of Prevention of Alzheimer's Disease. 2018. ↩︎
Giancardo et al. Keystroke dynamics as cognitive biomarker. Journal of Alzheimer's Disease. 2016. ↩︎
König et al. Speech analysis for Alzheimer's disease detection. Computers in Human Behavior. 2015. ↩︎
Fraser et al. Automated linguistic analysis of speech. Journal of Alzheimer's Disease. 2016. ↩︎
Lopez-de-Ipiña et al. On the selection of non-invasive methods for Alzheimer's disease. Expert Systems. 2013. ↩︎
Sattar et al. Speech-based automatic detection of early cognitive decline. Speech Communication. 2018. ↩︎
Pistacchi et al. Verbal fluency and Alzheimer's disease. Neurological Sciences. 2014. ↩︎
Khodabakhsh et al. Machine learning approaches for Alzheimer's disease detection. Computers in Biology and Medicine. 2015. ↩︎
Werner et al. Handwriting analysis for early detection of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2009. ↩︎
Drotár et al. Evaluation of handwriting features in early Alzheimer's disease. Journal of Clinical Monitoring and Computing. 2016. ↩︎
Müller et al. Digital clock drawing test. IEEE Journal of Biomedical and Health Informatics. 2018. ↩︎
Liao et al. Smart home-based health monitoring. Sensors. 2019. ↩︎
Hayes et al. Digital medication adherence monitoring. Journal of the American Medical Informatics Association. 2019. ↩︎
Austin et al. Passive monitoring technology in dementia care. Journal of Ambient Intelligence and Smart Environments. 2016. ↩︎